James L. Schardein

1.9k total citations
65 papers, 1.3k citations indexed

About

James L. Schardein is a scholar working on Pediatrics, Perinatology and Child Health, Molecular Biology and Health, Toxicology and Mutagenesis. According to data from OpenAlex, James L. Schardein has authored 65 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pediatrics, Perinatology and Child Health, 13 papers in Molecular Biology and 9 papers in Health, Toxicology and Mutagenesis. Recurrent topics in James L. Schardein's work include Carcinogens and Genotoxicity Assessment (9 papers), Effects and risks of endocrine disrupting chemicals (8 papers) and Pharmacological Effects and Toxicity Studies (6 papers). James L. Schardein is often cited by papers focused on Carcinogens and Genotoxicity Assessment (9 papers), Effects and risks of endocrine disrupting chemicals (8 papers) and Pharmacological Effects and Toxicity Studies (6 papers). James L. Schardein collaborates with scholars based in United States, Finland and Germany. James L. Schardein's co-authors include James E. Fitzgerald, D. H. Kaump, Stanley M. Kurtz, Judith A. Petrere, Bernard A. Schwetz, Lori A. Dostal, John A. Anderson, John A. Lucas, Kit A. Keller and Orest T. Macina and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, Environmental Health Perspectives and Annals of the New York Academy of Sciences.

In The Last Decade

James L. Schardein

62 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James L. Schardein United States 20 337 303 236 198 178 65 1.3k
K. S. Khera Canada 27 378 1.1× 420 1.4× 701 3.0× 217 1.1× 417 2.3× 71 2.1k
L. David Wise United States 18 311 0.9× 361 1.2× 261 1.1× 310 1.6× 105 0.6× 49 1.5k
Anthony K. Palmer United States 16 173 0.5× 134 0.4× 237 1.0× 88 0.4× 124 0.7× 38 793
Jerry R. Reel United States 28 505 1.5× 71 0.2× 281 1.2× 324 1.6× 134 0.8× 68 2.0k
RICHARD P. DOE United States 26 306 0.9× 117 0.4× 47 0.2× 126 0.6× 86 0.5× 65 2.1k
D. van der Heide Netherlands 23 347 1.0× 163 0.5× 57 0.2× 104 0.5× 52 0.3× 71 1.6k
Francesca Ietta Italy 27 361 1.1× 559 1.8× 422 1.8× 215 1.1× 236 1.3× 72 2.3k
Jeffrey A. Nisker Canada 19 210 0.6× 293 1.0× 113 0.5× 417 2.1× 30 0.2× 59 1.8k
Amar V. Singh United States 14 472 1.4× 114 0.4× 408 1.7× 84 0.4× 195 1.1× 30 1.3k
Brenda E. Barry United States 16 505 1.5× 56 0.2× 323 1.4× 80 0.4× 129 0.7× 26 2.1k

Countries citing papers authored by James L. Schardein

Since Specialization
Citations

This map shows the geographic impact of James L. Schardein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James L. Schardein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James L. Schardein more than expected).

Fields of papers citing papers by James L. Schardein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James L. Schardein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James L. Schardein. The network helps show where James L. Schardein may publish in the future.

Co-authorship network of co-authors of James L. Schardein

This figure shows the co-authorship network connecting the top 25 collaborators of James L. Schardein. A scholar is included among the top collaborators of James L. Schardein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James L. Schardein. James L. Schardein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schardein, James L., et al.. (2024). (132) MICONAZOLE VAGINAL CREAM AND ACQUIRED NEUROPROLIFERATIVE VESTIBULODYNIA. The Journal of Sexual Medicine. 21(Supplement_5).
2.
Schardein, James L.. (2000). Chemically Induced Birth Defects. 112 indexed citations
3.
Mackenzie, Karen, B.G. Boysen, T. E. A. Palmer, et al.. (1998). Sucrose Acetate Isobutyrate (SAIB): Three-generation Reproduction Study in the Rat and Teratology Studies in the Rat and Rabbit. Food and Chemical Toxicology. 36(2). 135–140. 2 indexed citations
4.
Schardein, James L.. (1996). Naturally Occurring Teratogens. Journal of Toxicology Toxin Reviews. 15(4). 369–391. 1 indexed citations
5.
Dostal, Lori A., James L. Schardein, & John A. Anderson. (1994). Developmental toxicity of the HMG‐CoA reductase inhibitor, atorvastatin, in rats and rabbits. Teratology. 50(6). 387–394. 67 indexed citations
6.
Schardein, James L., et al.. (1993). Neurotoxicity Evaluation of N,N-Diethyl-m-toluamide (DEET) in Rats. Toxicological Sciences. 21(3). 355–365. 1 indexed citations
7.
Schardein, James L., et al.. (1989). Potential Human Developmental Toxicants and The Role of Animal Testing in Their Identification and Characterization. PubMed. 19(3). 251–339. 47 indexed citations
8.
Gad, Shayne C., et al.. (1988). Inhalation Toxicity of Chlorotrifluoroethylene (CTFE). Journal of the American College of Toxicology. 7(5). 663–674. 6 indexed citations
9.
Petrere, Judith A., et al.. (1986). Teratology studies of ametantrone acetate in rats and rabbits. Teratology. 34(3). 271–278. 2 indexed citations
10.
Schardein, James L., et al.. (1985). Species sensitivities and prediction of teratogenic potential.. Environmental Health Perspectives. 61. 55–67. 71 indexed citations
11.
Baldwin, John A., et al.. (1983). Reproduction studies of BRL14151K and BRL25000: I. Teratology studies in rats. Chemotherapy. 31(2). 238–251. 1 indexed citations
12.
Schardein, James L.. (1980). Congenital abnormalities and hormones during pregnancy: A clinical review. Teratology. 22(3). 251–270. 85 indexed citations
13.
Schardein, James L.. (1976). Drugs as teratogens. Annals of Transplantation. 22. 507–517. 85 indexed citations
14.
Kurtz, Stanley M., et al.. (1976). Toxicological Studies on Gemfibrozil. Proceedings of the Royal Society of Medicine. 69(2_suppl). 15–23. 17 indexed citations
15.
Schardein, James L., et al.. (1973). Canine teratogenesis with an estrogen antagonist. Teratology. 7(2). 199–203. 5 indexed citations
16.
Kurtz, Stanley M., Roger A Fisken, D. H. Kaump, & James L. Schardein. (1968). Toxicity of 9-beta-D-arabinofuranosyladenine in mice and rabbits.. PubMed. 8. 180–9. 8 indexed citations
17.
Kurtz, Stanley M., et al.. (1967). The Effect of Long-Term Administration of Amopyroquin, a 4-Aminoquinoline Compound, on the Retina of Pigmented and Nonpigmented Laboratory Animals. Investigative Ophthalmology & Visual Science. 6(4). 420–425. 7 indexed citations
18.
Schardein, James L., et al.. (1967). The microscopy of “brown degeneration” in the adrenal gland of the mouse. The Anatomical Record. 159(3). 291–309. 7 indexed citations
19.
Schardein, James L. & D. H. Kaump. (1966). Auditory canal structures in rats as altered by aging and by the administration of tris(p-aminophenyl)carbonium pamoate.. PubMed. 26(8). 1625–32. 5 indexed citations
20.
Schardein, James L., et al.. (1965). EFFECTS OF ASPIRIN AND PHENYLBUTAZONE ON THE RABBIT BLASTOCYST. Reproduction. 10(1). 129–132. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026